Video

Current Challenges in Oncology Pharmacy

Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado.

Eric Dallara, RPh, pharmacist for the New England Cancer Specialists explains the current challenges in the industry, especially regarding payment plans and payment reform during the National Community Oncology Dispensing Association, Inc. in Denver, Colorado.

Transcript

I mean, currently, obviously, it’s just going past the first the first fill, or even the first fill period, where we’ve been pretty much shut out from a lot of these commercial plans, so that’s been very frustrating. Because patients won’t always understand that, “I come here for my treatment but you can’t provide me with the medication I need for my cancer,” and that’s kind of a hard thing sometimes. So that’s definitely one thing. Payment reform is another thing. We’re part of the OCM project too, so getting some insight into that, and then all the different things that they’re doing in Congress currently right now. So those are some challenges that I see.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com